BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25926730)

  • 1. Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model.
    Maswadeh HM; Aljarbou AN; Alorainy MS; Rahmani AH; Khan MA
    Int J Nanomedicine; 2015; 10():2847-55. PubMed ID: 25926730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model.
    Maswadeh HM; Aljarbou AN; Alorainy MS; Alsharidah MS; Khan MA
    Biomed Res Int; 2015; 2015():743051. PubMed ID: 25821817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of glycosphingosomes and liposomal doxorubicin shows increased activity against dimethyl-α-benzanthracene-induced fibrosarcoma in mice.
    Khan MA; Aljarbou AN; Aldebasi YH; Alorainy MS; Khan A
    Int J Nanomedicine; 2015; 10():6331-8. PubMed ID: 26504383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice.
    Khan A; Khan AA; Dwivedi V; Ahmad MG; Hakeem S; Owais M
    Mol Med; 2007; 13(5-6):266-76. PubMed ID: 17622310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of doxorubicin and dipalmitoylphosphatidylcholine liposomes.
    Mady MM; Shafaa MW; Abbase ER; Fahium AH
    Cell Biochem Biophys; 2012 Apr; 62(3):481-6. PubMed ID: 22194155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells.
    Yavlovich A; Singh A; Blumenthal R; Puri A
    Biochim Biophys Acta; 2011 Jan; 1808(1):117-26. PubMed ID: 20691151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy.
    Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M
    Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin.
    García MC; Calderón-Montaño JM; Rueda M; Longhi M; Rabasco AM; López-Lázaro M; Prieto-Dapena F; González-Rodríguez ML
    Int J Pharm; 2022 May; 619():121691. PubMed ID: 35331830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized thermosensitive liposomes for selective doxorubicin delivery: formulation development, quality analysis and bioactivity proof.
    Levacheva I; Samsonova O; Tazina E; Beck-Broichsitter M; Levachev S; Strehlow B; Baryshnikova M; Oborotova N; Baryshnikov A; Bakowsky U
    Colloids Surf B Biointerfaces; 2014 Sep; 121():248-56. PubMed ID: 25001189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation enhances radiation and doxorubicin-induced toxicity in solid tumor in vivo.
    Shil P; Kumar A; Vidyasagar PB; Mishra KP
    J Environ Pathol Toxicol Oncol; 2006; 25(4):625-32. PubMed ID: 17341203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy.
    Zamani P; Navashenaq JG; Teymouri M; Karimi M; Mashreghi M; Jaafari MR
    Life Sci; 2020 Jul; 252():117646. PubMed ID: 32272178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective Remote Loading of Doxorubicin into DPPC/Poloxamer 188 Hybrid Liposome to Retain Thermosensitive Property and the Assessment of Carrier-Based Acute Cytotoxicity for Pulmonary Administration.
    Tagami T; Kubota M; Ozeki T
    J Pharm Sci; 2015 Nov; 104(11):3824-3832. PubMed ID: 26228287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.
    Yahuafai J; Asai T; Oku N; Siripong P
    Biol Pharm Bull; 2018; 41(7):1103-1106. PubMed ID: 29962406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
    Krishna R; Mayer LD
    Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant delivery of doxorubicin and cisplatin through liposome-based thermosensitive nanoparticles: perspective in the treatment of cancer in animal models.
    Maswadeh HM; Khan A; Alorainy MS; Al-Wabel NA; Demetzos C
    Am J Cancer Res; 2023; 13(2):379-393. PubMed ID: 36895979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave-Triggered Smart Drug Release from Liposomes Co-encapsulating Doxorubicin and Salt for Local Combined Hyperthermia and Chemotherapy of Cancer.
    Jin Y; Liang X; An Y; Dai Z
    Bioconjug Chem; 2016 Dec; 27(12):2931-2942. PubMed ID: 27998076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Drug-Light Intervals Improve Liposomal Chemophototherapy in Mice Bearing MIA PaCa-2 Xenografts.
    Luo D; Carter KA; Geng J; He X; Lovell JF
    Mol Pharm; 2018 Sep; 15(9):3682-3689. PubMed ID: 29608312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis.
    Ferreira Ddos S; Faria SD; Lopes SC; Teixeira CS; Malachias A; Magalhães-Paniago R; de Souza Filho JD; Oliveira BL; Guimarães AR; Caravan P; Ferreira LA; Alves RJ; Oliveira MC
    Int J Nanomedicine; 2016; 11():3737-51. PubMed ID: 27563241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.